RSS-Feed abonnieren
DOI: 10.1055/s-0031-1276992
Ernährung bei Nierenerkrankungen
Nutrition in Renal DiseasePublikationsverlauf
Publikationsdatum:
02. Dezember 2011 (online)

Zusammenfassung
Ernährungsempfehlungen bei Nierenerkrankungen richten sich nach dem Krankheitsstadium (CKD-Stadien [CKD: chronische Nierenerkrankung]), den Begleiterkrankungen und den Sekundärfolgen der Niereninsuffizienz. Diätetische Maßnahmen verfolgen primär präventive Ziele wie die Progressionshemmung der Niereninsuffizienz, die Aufrechterhaltung eines adäquaten Ernährungszustands und die Verhinderung von Hyperphosphatämie oder Hyperkaliämie. Zur Progressionshemmung chronischer Nierenerkrankungen wird neben den etablierten medikamentösen Interventionen nur noch in den CKD-Stadien 1–3 eine diätetische Eiweißrestriktion auf 0,6–0,8 g / kg / d empfohlen. Für das Management einer Hyperphosphatämie stehen sowohl diätetische als auch medikamentöse (Phosphatbinder) Behandlungsoptionen zur Verfügung. Diätetische Phosphatrestriktionen dürfen den Ernährungszustand allerdings nicht negativ beeinflussen. In den CKD-Stadien 4 und 5 besteht ein hohes Risiko für die Entwicklung einer Mangelernährung, die durch einen gesteigerten Proteinkatabolismus bei gleichzeitig gehemmter Proteinsynthese charakterisiert ist. Die Entwicklung einer Malnutrition muss frühzeitig erkannt und konsequent behandelt werden. Das Ziel ernährungsmedizinischer Maßnahmen bei Mangelernährung ist die komplette Abdeckung des individuellen Energie- und Eiweißbedarfs, im Bedarfsfall auch durch orale oder enterale (PEG [perkutane endoskopische Gastrostomie]) Verabreichung eiweißreicher und hochkalorischer Zusatznahrung.
Abstract
Dietary recommendations for patients with chronic renal disease need to take into consideration the CKD stage, the variety of comorbidities, and the plethora of secondary consequences of renal insufficiency. Primary aims of dietary interventions in kidney disease include retardation of disease progression, maintenance of a good nutritional state and prevention of hyperphosphatemia or hyperkalemia. In CKD stages 1–3 retardation of disease progression can be achieved by medicinal interventions in combination with dietary protein restriction to 0.6–0.8 g / kg / day. The management of hyperphosphatemia includes dietary as well as medicinal (phosphate binders) measures. However, dietary phosphate control should not compromise protein intake. There is an increased risk for development of malnutrition in CKD stages 4 and 5, which is characterized by stimulation of muscle proteolysis and inhibition of protein synthesis. The development of malnutrition needs to be recognized early and addressed with scrutiny. Any dietary interventions for the management of malnutrition aim at improving energy and protein intake, either by dietary counselling or, if required, by prescription of oral or enteral (PEG / PEJ) energy and protein supplements.
Schlüsselwörter
Mangelernährung - Hyperphosphatämie - arterielle Hypertonie - Hyperlipidämie
Keywords
malnutrition - hyperphosphatemia - arterial hypertension - hyperlipidemia
Literatur
- 1
Levey A S, Coresh J, Balk E et al.
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation,
classification, and stratification.
Ann Intern Med.
2003;
139
137-147
MissingFormLabel
- 2
Manjunath G, Sarnak M J, Levey A S.
Prediction equations to estimate glomerular filtration rate: an update.
Curr Opin Nephrol Hypertens.
2001;
10
785-792
MissingFormLabel
- 3
Hallan S I, Coresh J, Astor B C et al.
International comparison of the relationship of chronic kidney disease prevalence
and ESRD risk.
J Am Soc Nephrol.
2006;
17
2275-2284
MissingFormLabel
- 4 Bello A, Kawar B, El Kossi M et al. Epidemiology and pathophysiology of chronic kidney disease.. In: Floege J, Johnson R J, Feehally J, eds Comprehensive clinical nephrology.. 4th ed. St Louis, Missouri: Elsevier Inc; 2010: 907-918
MissingFormLabel
- 5
Levin N W, Gotch F A, Kuhlmann M K.
Factors for increased morbidity and mortality in uremia: hyperphosphatemia.
Semin Nephrol.
2004;
24
396-400
MissingFormLabel
- 6
Bailey J L, Wang X, England B K et al.
The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting
transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome
pathway.
J Clin Invest.
1996;
97
1447-1453
MissingFormLabel
- 7
Fouque D, Kalantar-Zadeh K, Kopple J D et al.
A proposed nomenclature and diagnostic criteria for protein – energy wasting in acute
and chronic kidney disease.
Kidney Int.
2008;
73
391-398
MissingFormLabel
- 8
Stenvinkel P, Ketteler M, Johnson R J et al.
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia
– the good, the bad, and the ugly.
Kidney Int.
2005;
67
1216-1233
MissingFormLabel
- 9
Ikizler T A, Greene J H, Wingard R L et al.
Spontaneous dietary protein intake during progression of chronic renal failure.
J Am Soc Nephrol.
1995;
6
1386-1391
MissingFormLabel
- 10
Ikizler T A, Pupim L B, Brouillette J R et al.
Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation.
Am J Physiol Endocrinol Metab.
2002;
282
E107-E116
MissingFormLabel
- 11
Enia G, Sicuso C, Alati G et al.
Subjective global assessment of nutrition in dialysis patients.
Nephrol Dial Transplant.
1993;
8
1094-1098
MissingFormLabel
- 12
Moissl U M, Wabel P, Chamney P W et al.
Body fluid volume determination via body composition spectroscopy in health and disease.
Physiol Meas.
2006;
27
921-933
MissingFormLabel
- 13
Fouque D, Aparicio M.
Eleven reasons to control the protein intake of patients with chronic kidney disease.
Nat Clin Pract Nephrol.
2007;
3
383-392
MissingFormLabel
- 14
Klahr S, Levey A S, Beck G J et al.
The effects of dietary protein restriction and blood-pressure control on the progression
of chronic renal disease. Modification of Diet in Renal Disease Study Group.
N Engl J Med.
1994;
330
877-884
MissingFormLabel
- 15
Clinical practice guidelines for nutrition in chronic renal failure. K / DOQI, National
Kidney Foundation.
Am J Kidney Dis.
2000;
35
1-140
MissingFormLabel
- 16
Hansen H P, Tauber-Lassen E, Jensen B R et al.
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.
Kidney int.
2002;
62
220-228
MissingFormLabel
- 17
Fouque D, Vennegoor M, Ter Wee P et al.
EBPG guideline on nutrition.
Nephol Dial Transplant.
2007;
22
(S 02)
ii45-ii87
MissingFormLabel
- 18
Brunori G, Viola B F, Parrinello G et al.
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly:
a prospective randomized multicenter controlled study.
Am J Kidney Dis.
2007;
49
569-580
MissingFormLabel
- 19
Steiber A L, Kopple J D.
Vitamin Status and Needs for People with Stages 3–5 Chronic Kidney Disease.
J Ren Nutr.
2011;
21
355-368
MissingFormLabel
- 20
Boaz M, Smetena S, Weinstein T et al.
Secondary prevention with antioxidants of cardiovascular disease in end stage renal
disease (SPACE): randomized placebo-controlled trials.
Lancet.
2000;
356
1213-1218
MissingFormLabel
- 21
Mann J FE, Lonn E M, Yi Q et al.
Effects of vitamin E on cardiovascular outcomes in people with mild- to-moderate renal
insufficiency: results of the HOPE study.
Kidney Int.
2004;
65
1375-1380
MissingFormLabel
- 22
Kopple J D, Feroze U.
The effect of obesity on chronic kidney disease.
J Ren Nutr.
2011;
21
66-71
MissingFormLabel
- 23
Baigent C, Landray M J, Reith C et al.
The effects of lowering LDL cholesterol with simvastatin and ezetimibe in patients
with chronic kidney disease (Study of Heart an Renal Protection): a randomised placebo-controlled
trial.
Lancet.
2011;
377
2181-2192
MissingFormLabel
- 24
Wanner C, Krane V, Maerz W et al.
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
N Engl J Med.
2005;
353
238-248
MissingFormLabel
- 25
Kuhlmann M K.
Management of Hyperphosphatemia.
Hemodial Int.
2006;
10
338-345
MissingFormLabel
- 26
Noori N, Kalantar-Zadeh K, Kovesdy C P et al.
Association of dietary phosphorus intake and phosphorus-to-protein ratio with mortality
in hemodialysis patients.
Clin J Am Soc Nephrol.
2010;
5
683-692
MissingFormLabel
- 27
Kalantar-Zahed K, Gutekunst L, Mehrotra R et al.
Understanding sources of dietary phosphorus in the treatment of patients with chronic
kidney disease.
Clin J Am Soc Nephrol.
2010;
5
519-530
MissingFormLabel
- 28
Moe S M, Zidehsarai M P, Chambers M A et al.
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in
chronic kidney disease.
Clin J Am Soc Nephrol.
2011;
6
257-264
MissingFormLabel
- 29
Kuhlmann M K, Hoechst S, Landthaler I.
Patient empowerment in the management of hyperphosphatemia.
Int J Artif Organs.
2007;
30
1008-1013
MissingFormLabel
- 30
Ahlenstiel T, Pape L, Ehrich J H et al.
Self-adjustment of phosphate binder dose to meal phosphorus content improves management
of hyperphosphataemia in children with chronic kidney disease.
Nephrol Dial Transplant.
2010;
25
3241-3249
MissingFormLabel
- 31
Sullivan C, Sayre S S, Leon J B et al.
Effect of food additives on hyperphosphatemia among patients with end-stage renal
disease: a randomized controlled trial.
JAMA.
2009;
301
629-635
MissingFormLabel
- 32 Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and
Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium and
Vitamin D.. Washington, DC: National Academy Press; 2010
MissingFormLabel
- 33
Pupim L B, Flakoll P J, Levenhagen D K et al.
Exercise augments the acute anabolic effects of intradialytic parenteral nutrition
in chronic hemodialysis patients.
Am J Physiol Endocrinol Metab.
2004;
286
E589-597
MissingFormLabel
- 34
Kuhlmann M K, Schmidt F, Koehler H.
High protein / energy vs. standard protein / energy nutritional regimen in the treatment
of malnourished hemodialysis patients.
Mineral Electrolyte Metabolism.
1999;
25
306-310
MissingFormLabel
- 35
Stratton R J, Bircher G, Fouque D et al.
Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic
review and meta-analysis.
Am J Kidney Dis.
2005;
46
387-405
MissingFormLabel
- 36
Cano N J, Fouque D, Roth H et al.
Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis
patients: a 2-year multicenter, prospective, randomized study.
J Am Soc Nephrol.
2007;
18
2583-2591
MissingFormLabel
- 37
Johansen K L, Painter P L, Sakkas G K et al.
Effects of resistance exercise training and nandrolone decanoate on body composition
and muscle function among patients who receive hemodialysis: A randomized, controlled
trial.
J Am Soc Nephrol.
2006;
17
2307-2314
MissingFormLabel
- 38
Feldt-Rasmussen B, Lange M, Sulowicz W et al.
Growth hormone treatment during hemodialysis in a randomized trial improves nutrition,
quality of life, and cardiovascular risk.
J Am Soc Nephrol.
2007;
18
2161-2171
MissingFormLabel
- 39
Kuhlmann M K, Levin N W.
Potential interplay between nutrition and inflammation in dialysis patients.
Contrib Nephrol.
2008;
161
76-82
MissingFormLabel
- 40
Nafar M, Noori N, Jalali-Farahani S et al.
Mediterranean diets are associated with a lower incidence of metabolic syndrome one
year following renal transplantation.
Kidney Int.
2009;
76
1199-1206
MissingFormLabel
- 41 D-A-CH .Referenzwerte für die Nährstoffzufuhr.. 1. Aufl. 3. korrigierter Nachdruck. Neustadt an der Weinstraße: Neuer Umschau Buchverlag; 2008
MissingFormLabel
Prof. Dr. med. Martin K. Kuhlmann
Innere Medizin – Nephrologie, Vivantes Klinikum im Friedrichshain
Landsberger Allee 49
10249 Berlin
eMail: Martin.kuhlmann@vivantes.de